Transgenic expression of PD mutant LRRK2G2019S or LRRK2R1441C in lrk-1 deletion mutants efficiently supresses the axonal abnormality phenotype exhibited in lrk-1 or glo-1 deletion mutants [189], suggesting high functional conservation. This evidence concerns the gene GLO1 and Parkinson disease.